Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma

Table 3 Treatment outcomes in patients with solitary huge hepatocellular carcinoma receiving hepatic resection or transarterial chemoembolization, before and after propensity score matching n (%)

	Before matching			After matching
	HR (n = 180)	TACE (n = 67)	P-value	HR (n = 61)	TACE (n = 61)	P-value
30-d mortality	2 (1.1)	1 (1.5)	1.000	1 (1.6)	1 (1.6)	1.000
90-d mortality	6 (3.3)	2 (3.0)	1.000	3 (4.9)	2 (3.3)	1.000
Postoperative complications	36 (20.0)	11 (16.4)	0.524	14 (23.0)	10 (16.4)	0.362
Liver failure	5 (2.8)	5 (7.5)	0.194	4 (6.6)	4 (6.6)	1.000
Bleeding	4 (2.2)	0 (0)	0.507	1 (1.6)	0 (0)	1.000
Wound infection	5 (2.8)	0 (0)	0.384	2 (3.3)	0 (0)	0.476
Puncture hematoma	0 (0)	3 (4.5)	0.019	0 (0)	3 (4.9)	0.242
Bile fistula	2 (1.1)	0 (0)	1.000	0 (0)	0 (0)	1.000
Pulmonary infection	6 (3.3)	3 (4.5)	0.964	2 (3.3)	3 (4.9)	1.000
Incision dehiscence	2 (1.1)	0 (0)	1.000	0 (0)	0 (0)	1.000
Abdominal infection	3 (1.7)	0 (0)	0.565	1 (1.6)	0 (0)	1.000
Hydrothorax	7 (3.9)	0 (0)	0.228	4 (6.6)	0 (0)	0.127
Intestinal obstruction	2 (1.1)	0 (0)	1.000	0 (0)	0 (0)	1.000

HR: Hepatic resection; TACE: Transarterial chemoembolization.